Skip to content

Randomized, double-blind, placebo-controlled parallel-group comparative study to evaluate the efficacy in probiotics on maintaining physical condition

Randomized, double-blind, placebo-controlled parallel-group comparative study to evaluate the efficacy in probiotics on maintaining physical condition - Clinical study to evaluate the efficacy in probiotics on maintaining physical condition

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000045469
Enrollment
200
Registered
2021-09-14
Start date
2021-09-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Intake of powdered probiotic for 12 weeks Intake of powdered placebo for 12 weeks

Sponsors

Matsumoto City Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Subjects of both sexes aged 20 years or older and younger than 75 years.

Exclusion criteria

Exclusion criteria: 1) Subjects who have disease or serious medical history in liver, kidney, heart, lung, gastrointestinal tract, blood, endocrine system, or metabolism, etc. 2) Subjects who regularly use oral or nasal medications 3) Subjects with severe perennial or seasonal allergic symptoms (those who develop symptoms during this study period and take steroids) 4) Subjects who are scheduled to be vaccinated against COVID-19 from two weeks before the start of this study to the end of this study 5) Subjects with serious medication allergy, food allergy, or history of these 6) Subjects who are pregnant, under lactation or expecting to be pregnant during this study 7) Subjects who participated in other study within 1 month prior to obtaining informed consent 8) Any candidates considered to be inappropriate for this study by the principal investigator based on their background, physical examination, etc.

Design outcomes

Primary

MeasureTime frame
Subjective symptoms of physical conditions

Countries

Japan

Contacts

Public ContactShimamura Akira

Matsumoto Health Lab None

info@m-health-lab.jp0263-39-1139

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026